Innovate UK - AMR SWITZERLAND Global Business Innovation Programme (GBIP)

Monday 12th March 2024

We are pleased to announce Veirulence’s successful application to join the Innovate UK - AMR SWITZERLAND Global Business Innovation Programme (GBIP).

Veirulence will be attending the 9th annual AMR conference in Basel as part of the programme and will build collaborations and partnerships to explore innovation opportunities.

LinkedIn announcement here!

For more information about the programme, please visit the UKRI website.

More information

Innovate UK - AMR SWEDEN Global Business Innovation Programme (GBIP)

Monday 12th August 2024

We are pleased to announce Veirulence’s successful application to join the Innovate UK - AMR SWEDEN Global Business Innovation Programme (GBIP).

Veirulence will be visiting Sweden in November to build collaborations and partnerships and explore innovation opportunities.

LinkedIn post here!

For more information about the programme, please visit the UKRI website.

More information

Innovate UK Biomedical Catalyst Accelerator - Future Medicines

Thursday 16th October 2025

We are pleased to announce Veirulence’s participation in the Innovate UK Biomedical Catalyst Accelerator - Future Medicines.

During the programme, Veirulence will benefit from engagement with drug discovery, development, and regulation experts. The Pre-Accelerator programme will run November-December, with a select number of companies progressing to the Accelerator programme in January-March 2026.

LinkedIn announcement here!

For more information about the programme, please visit the UKRI website.

More information

Vinnova - DOUBLE BARRIER

Monday 3rd November 2025

We are pleased to be awarded a grant by Vinnova as part of an international collaboration with Sahlgrenska University Hospital, Imperial College London, The National Institutes of Health, and Research Institutes of Sweden.

The DOUBLE BARRIER project aims to integrate AI-driven multi-omics diagnostics and next-generation prevention strategies to combat bacterial infections and antimicrobial resistance (AMR).

LinkedIn announcement here!

For more information about the programme, please visit the Vinnova website.

More information